In addition, it is not clear yet that combined treatment with trametinib or PD0325901 and perifosine suppressed the tumor growth in xenograft mouse model of MEK inhibitor resistance primary and acquired colorectal cancer cells. Here, MAP2K7 is linked to neoplasm.